IRLA QUINCE THERAPEUTICS INC
FollowStock (common), issuer CIK 1662774
Filings received so far for Q3 2026: 1 13F filer report a position in IRLA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- PERCEPTIVE ADVISORS LLC(group PERCEPTIVE ADVISORS LLC)
912,853 shares, 8.4% in a 13G as of 2026-10-06,0001193125-26-421651
Accepted , ingested - Foresite Capital Fund VI LP (group Foresite Capital Management VI LLC)
652,039 shares, 6% in a 13G as of 2026-10-06,0001104659-26-115859
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Fortitude Family Office, LLC | 41 | $1.27K | <0.01% | +1 | 13F-HRTimeline |
Events
Foresite Capital Fund VI LP and 4 other reporting persons reported 652,039 IRLA shares, 6% of the class, as of 2026-10-06, in a 13G filed 2026-10-14. 0001104659-26-115859
Accepted , ingestedPERCEPTIVE ADVISORS LLC and 2 other reporting persons reported 912,853 IRLA shares, 8.4% of the class, as of 2026-10-06, in a 13G filed 2026-10-14. 0001193125-26-421651
Accepted , ingested